» Articles » PMID: 34992029

Prognostic Significance of the Ratio of Surgically Resected to Radiologically Detected Lung Nodules in Patients with Metastatic Osteosarcoma

Overview
Journal Surg Oncol
Date 2022 Jan 7
PMID 34992029
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Patients And Methods: Data from patients with metastatic osteosarcoma who underwent metastasectomy between January 2009 and December 2020, in a single center, were reviewed. The relationships between survival and the SR/RD ratio, timing of lung metastases, number of nodules, laterality, and presence of tumor necrosis at first metastasectomy were investigated.

Results: Among the 125 metastatic osteosarcoma patients, 80 patients had an SR/RD ratio ≤1. The median duration of follow-up was 72 months, ranging from 6 to 118 months. The five-year overall survival (OS) and postmetastasectomy event-free survival (EFS) for all patients were 36.5% and 18.1%, respectively. The five-year OS of patients with a low SR/RD ratio was 49.6% and that of patients with a high SR/RD ratio was 11.8 (P = 0.001). The two-year postmetastasectomy EFS rates of the high and low ratio groups were 24.1% and 9.4%, respectively (P = 0.001). The SR/RD ratio, number of nodules, and tumor necrosis had significant effects on OS and postmetastasectomy EFS in univariate analysis. A Cox proportional hazard model demonstrated that tumor necrosis and an SR/RD ratio >1 were associated with OS (HR = 1.8 and 2.01) and postmetastasectomy EFS (HR = 1,69 and 1.97).

Conclusions: A high SR/RD ratio of greater than 1 and poor tumor necrosis were significantly associated with poor survival among patients with metastatic osteosarcoma who had lung metastasectomy. The high SR/RD ratio may be a surrogate outcome for incomplete metastatic tumor resection.

Citing Articles

Comparative outcomes of video-assisted thoracic surgery versus open thoracic surgery in pediatric pulmonary metastasectomy: a systematic review and meta-analysis.

Noleto da Nobrega Oliveira R, Peres C, Oliveira A, Onyeji P, Kemczenski F Pediatr Surg Int. 2024; 41(1):34.

PMID: 39699640 DOI: 10.1007/s00383-024-05934-3.


The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas.

Longhi A, Marrari A, Tetta C, Parmeggiani A, Parise O, Ferrari C Cancers (Basel). 2024; 16(21).

PMID: 39518034 PMC: 11544818. DOI: 10.3390/cancers16213593.


Survival outcomes and surgical morbidity based on surgical approach to pulmonary metastasectomy in pediatric, adolescent and young adult patients with osteosarcoma.

Kuo C, Malvar J, Chi Y, Kim E, Shah R, Navid F Cancer Med. 2023; 12(20):20231-20241.

PMID: 37800658 PMC: 10652329. DOI: 10.1002/cam4.6491.


Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors.

Shell D Gen Thorac Cardiovasc Surg. 2023; 71(5):263-271.

PMID: 36631707 DOI: 10.1007/s11748-023-01905-y.